Combining STING Agonists with PARP Inhibitors Mounts an NK-Dependent Defense against Therapy-Resistant Breast Cancer.

待确认 20 由肉神发布于 2026/6/20 18:53:58

DOI:10.1158/0008-5472.can-25-0831
作者：Zahra Gohari,Lora Stojanovic,Feyruz V Rassool
文献类型：期刊论文
补充材料：只需要正文

American Association for Cancer Research (AACR)

Abstract：Breast cancers with BRCA1 or BRCA2 mutations are defective in repair of DNA double-strand breaks by homologous recombination, resulting in compensatory error-prone repair that causes genomic

应助信息

等待求助人确认

求助人未确认前，本求助不能再次应助。36小时后系统将自动确认应助成功。本求助将自动关闭。

2小时前

小贝

f83c86846c9611f1bbee34735aa3bc31.pdf

3小时前

Book学术机器人

2026/6/20 18:53:58 未找到该文献，机器人已退出，请等待人工下载

2026/6/20 18:53:58 Book学术AI机器人收到请求，开始寻找文献

2026/6/20 18:53:58 已向机器人发送请求

3小时前

肉神发布求助

上一个求助:其它数据库Naturally Fractured Carbonate Reservoir Characterization: A Case Study of a Mature High-Pour Point Oil Field in Hungary 下一个求助:其它数据库Digitoxin in Patients with Heart Failure and Reduced Ejection Fraction. Reply.